(Q43814867)

27 November 2017

title

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis (English)

1 reference

27 November 2017

0 references

1 reference

Colombo C

1

1 reference

27 November 2017

Setchell KD

2

1 reference

27 November 2017

Podda M

3

1 reference

27 November 2017

Crosignani A

4

1 reference

27 November 2017

Roda A

5

1 reference

27 November 2017

Curcio L

6

1 reference

27 November 2017

Ronchi M

7

1 reference

27 November 2017

Giunta A

8

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 September 1990

1 reference

The Journal of Pediatrics

27 November 2017

published in

1 reference

27 November 2017

volume

117

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

482-489

1 reference

Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Liver disease and common-bile-duct stenosis in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Excessive Fecal Taurine Loss Predisposes to Taurine Deficiency in Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Serum bile acid composition in patients with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Malabsorption of Bile Acids in Children with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Effect of taurine supplements on fat absorption in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Ursodeoxycholic acid for primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Development of a sensitive enzyme immunoassay for plasma and salivary steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Production of a high-titer antibody to bile acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile acid composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Ursodeoxycholic acid in biliary atresia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Effect of taurine supplementation on fat and bile acid absorption in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981103-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(05)81103-5

1 reference

27 November 2017

1 reference